Neuigkeit zur PetitionStop contaminated cabin air in aircraft!A Call for Members of the UK Parliament to Demand Answers
Trudie DaddCrewkerne, ENG, Vereinigtes Königreich
12 Dec 2025

Photo: (Copyright 2025) Wallpaper Cave

 

Over several decades, evidence has accumulated linking chronic, low-level exposure to fumes onboard aircraft - a complex mixture of organophosphates, solvents, hydrocarbons, ultrafine particles, carbon monoxide, and thermally degraded oils, to multi-system dysfunction.

This document integrates early government warnings with current biochemical, oncological, and neuropathological research to explain how cumulative exposure can lead not only to neurological, hepatic, cardiovascular, endocrine, and immune injury, but also to cancers, given the presence of proven carcinogens such as benzene and the central role of chronic oxidative stress in driving disease.

 

Historical Context

In 1951, ‘the Working Party on Precautionary Measures against Toxic Chemicals used in Agriculture’ led by Professor Solly Zuckerman warned in their report to The Minister of Agriculture and Fisheries U.K. that repeated low-level exposure to organophosphate (OP) compounds used in pesticides/insecticides could cause cumulative poisoning by progressively lowering cholinesterase levels, rendering individuals increasingly susceptible to further doses. Although science at that time focused mainly on the enzyme inhibition mechanism, this early recognition of chronic toxicity laid the foundation for understanding the persistence of low-level OP injury. Pesticides are chemical formulations which include OP’s, solvents and hydrocarbons.

See Section VI - Dangers to Man..Mode of Action:

http://www.oprus2001.co.uk/zuck1951.htm

 

Modern Mechanistic Understanding

Today, it is known that the toxicity of OPs extends beyond cholinesterase inhibition. These compounds form covalent bonds (adducts) with numerous proteins, altering their structure and function—a process sometimes described as “protein decoration.” 

Adducted proteins can trigger immune recognition and autoantibody formation, contributing to chronic inflammation and neuroimmune dysfunction. Moreover, OPs can cross the blood-brain barrier (BBB), particularly under repeated or prolonged low-dose exposure. Once in the central nervous system, they disrupt mitochondrial function, impairing ATP generation and increasing oxidative stress. 

This combination of oxidative damage, impaired repair processes, and excitotoxicity underlies the neuronal and glial injury seen in chronic exposure cases. (Abou-Donia et al. 2013)

 

Systemic Pathophysiology

The liver, responsible for metabolizing organophosphates and related volatile organic compounds (VOCs), becomes a site of sustained oxidative load. 

Some OP metabolites—particularly from tricresyl phosphate (eg. TOCP and MOCP) are more toxic than their parent compounds. The continuous need to process these substances leads to mitochondrial strain, impaired detoxification capacity, and downstream metabolic stress. 

Cognitive dysfunction, endocrine disruption, gastrointestinal issues, respiratory and cardiac complications, peripheral neuropathy, fatigue and immune dysregulation can arise from this interconnected network of mitochondrial injury, oxidative stress and persistent neuroinflammation. 

Repeated low-level exposure to fumes from a complex chemical mixture that includes  OP’s can prevent full recovery between exposures leading to cumulative, multi-system injury. 

 

Disregarded by UK Government “Scientific Experts”
The pathways and mechanisms of injury from contaminated air in aircraft have been consistently disregarded within the UK’s scientific committees. Their knowledge and approach remain decades behind modern toxicology and environmental health science. This is especially concerning given that aircraft cabins are enclosed environments with no filtration or monitoring of the bleed air drawn directly from the engines, meaning that any contaminants introduced into the air supply are circulated and inhaled by everyone onboard.

The scale of health effects from airborne ultrafine particles has been understood for years. As reported by The Guardian in 2019:

“Air pollution is a ‘public health emergency’, according to the World Health Organization, with more than 90% of the global population enduring toxic outdoor air. New analysis indicates 8.8m early deaths each year – double earlier estimates – making air pollution a bigger killer than tobacco smoking.

But the impact of different pollutants on many ailments remains to be established, suggesting well-known heart and lung damage is only ‘the tip of the iceberg’.

‘Air pollution can harm acutely, as well as chronically, potentially affecting every organ in the body,’ conclude the scientists from the Forum of International Respiratory Societies in the two review papers, published in the journal Chest. ‘Ultrafine particles pass through the lungs, are readily picked up by cells, and carried via the bloodstream to expose virtually all cells in the body.’”

This widely accepted science highlights an alarming inconsistency: the same ultrafine particles known to damage every organ in the body are present in aircraft cabin air, yet UK Government reviews continue to ignore these mechanisms entirely.

https://www.theguardian.com/environment/ng-interactive/2019/may/17/air-pollution-may-be-damaging-every-organ-and-cell-in-the-body-finds-global-review

 

Aircraft Cabin Air Quality, Regulatory Failure, and the Need for an Independent Scientific Review

Prepared for:
Members of Parliament, Parliamentary Researchers, and Policy Advisers

Subject:
Structural failures in the UK Government’s assessment of aircraft cabin air toxicity

Purpose:
To inform MPs of urgent issues requiring Parliamentary scrutiny, public accountability, and regulatory reform.

 

1. Summary of Key Concerns

This briefing outlines evidence that the UK Government’s official assessment of aircraft cabin air quality — published by the Committee on Toxicity (COT) in April 2024 — is not scientifically reliable and should not be used to guide policy, healthcare, or aviation regulation.

Link to the COT Statement:
https://cot.food.gov.uk/Statement%20on%20Aircraft%20Cabin%20Air%20Quality#executive-summary

Key findings:

  • The COT Statement was not written by the Committee, but drafted externally by IEH Consulting Limited, a private consultancy.
  • UKHSA has refused to disclose the authorship, preventing scrutiny and undermining transparency.
  • The Department for Transport (DfT) scoped the review in a way that excluded repeated low-level exposure, relied on inappropriate regulatory exposure limits, and omitted the fume-event scenario entirely.
  • Critical toxicology — including organophosphate neurotoxicity, protein adduct biomarkers, pyrolysis products, ultrafine particles, mitochondrial injury, immune and endocrine disruption — was omitted.
  • The Civil Aviation Authority (CAA)’s language and framing appear throughout the drafts.
  • The final COT Statement is almost identical to the IEH drafts, with only minor editorial changes.

These findings strongly suggest regulatory capture and raise serious questions about the integrity of Government toxicology assessments relating to aviation safety.

 

2. Why This Matters

Aviation workers and passengers are at risk.

Crew and passengers may be exposed to a complex mixture of toxic by-products not only during recognisable “fume events”, when high levels of contaminants enter cockpits and cabins, but on every flight, due to continuous low-level exposure on all commercial aircraft except the Boeing 787.

Key contaminants include:

  • organophosphates
  • volatile organic compounds (VOCs)
  • thermally degraded engine oils
  • carbon monoxide
  • ultrafine particles

Symptoms consistently reported by affected individuals include:

  • neurological dysfunction (central and peripheral)
  • respiratory complications
  • immune dysregulation
  • endocrine disturbance
  • chronic fatigue
  • gastrointestinal issues
  • cardiac irregularities

Current medical guidance to clinicians is based on the flawed COT review, leading to misdiagnosis, dismissal of symptoms, and lack of access to appropriate care.

 

3. Evidence of Regulatory and Scientific Failure

3.1 Outsourced drafting

The IEH Consulting Limited “First Draft” and “Second Draft” match the final COT Statement in:

  • structure
  • omissions
  • evidence base
  • conclusions

The COT did not substantially alter, expand, or challenge the drafts.

3.2 Concealed authorship

UKHSA has refused to release the names of those who drafted the reports — a serious breach of scientific transparency and public accountability.

3.3 Use of an incorrect and outdated exposure model

The review assessed only “normal cabin air”, assuming it represents clean air, despite the absence of sensors or monitoring equipment onboard aircraft.
Contaminated “fume events” were treated as rare anomalies, not examined as part of the exposure continuum.

This approach ignores:

  • modern toxicology
  • continuous low-level exposure
  • cumulative burden
  • individual susceptibility
  • peak-on-chronic exposure dynamics

Continuous exposure

Bleed air contains:

  • organophosphates
  • ultrafine particles
  • VOCs/SVOCs
  • pyrolysis fragments

even without a visible fume event.

Cumulative burden

Aircrew are exposed:

  • on every flight
  • repeatedly
  • for years or decades
  • without biological recovery time

Individual susceptibility

Risk varies with:

  • genetic detoxification capacity (e.g., PON1, CYP450 profiles)
  • mitochondrial function
  • neurological and immune vulnerability

Acute-on-chronic exposure

A fume event is not an isolated spike, but a peak exposure layered onto chronic exposure.

Outdated toxicology assumptions

The COT review relied on models that:

  • assume steady-state exposure
  • ignore persistent low-dose toxicology
  • dismiss cumulative harm
  • disregard interactions between low-dose and peak-dose events
  • omit chronic organophosphate neurotoxicity

This renders the exposure assessment invalid for aviation environments.


3.4 Exclusion of relevant toxicology

A number of well-established toxicological domains were excluded, despite their direct relevance to aircraft cabin exposures.

The review omitted:

  • Organophosphate research, including DEFRA projects VM2300, VM2301, VM2302, VM02116, VM02117 and VM0299 from the early 2000’s — incorrectly dismissed by the COT in 2007 despite demonstrating confirmed physical effects, biomarker changes, and recommending further research.*
  • Mitochondrial toxicity, central to multi-system injury.
  • Immune dysregulation, including cytokine activation and impaired T-cell function.
  • Genotoxicity, including DNA and cellular damage.
  • Synergistic toxicity between OPs, solvents, and ultrafine particles.
  • Chronic OP and VOC injury mechanisms, central to aviation exposures.
  • Endocrine disruption, including hypothalamic–pituitary axis effects.
  • Ultrafine particle toxicology, including transport of chemicals into blood and brain.
  • Pyrolysis chemistry, which governs how oils and hydraulic fluids convert into more toxic breakdown products.
  • Biomarker studies, including OP–protein adducts (albumin, AChE, BChE), oxidative stress markers, mitochondrial markers, and liver enzyme responses.
  • Toxicity from cabin pesticide sprays (permethrin, 1R-trans-phenothrin) and their synergistic interactions with OPs.

*Summary of DEFRA Projects VM2300, VM2301, VM2302, VM02116, VM02117, VM0299

These DEFRA-funded studies investigated low-level organophosphate pesticide exposure in agricultural workers. They demonstrated:

  • measurable neurological, cognitive, and autonomic effects
  • biomarker changes including altered cholinesterase function and oxidative stress
  • peripheral neuropathy and impaired neurophysiological performance
  • mood, memory, and concentration impairments
  • individual susceptibility based on genetic and metabolic differences
  • clear recommendations for further research. 

The COT’s 2007 dismissal of these findings is widely regarded as scientifically flawed and influenced by political and regulatory considerations rather than the weight of evidence. 

3.5 Lack of independent scientific input

No independent neurologists, toxicologists, occupational health experts, or researchers specialising in OP, VOC, UFP or CO injury were consulted.

3.6 Repetition of CAA/DfT language

The documents repeat established regulatory talking points:

  • “fume events are rare”
  • “exposures are low”
  • “evidence of harm is inconsistent”
  • No critical evaluation or examination of contrary evidence was undertaken.

 

4. Consequences of the Flawed Review

Public health impacts

  • NHS clinicians told “no evidence of harm”
  • Injured crew misdiagnosed or dismissed
  • Passengers unprotected
  • Ongoing exposure with no mitigation


Regulatory impacts

  • No mandatory onboard sensors
  • No central fume-event reporting
  • Manufacturers and airlines shielded from accountability


Legal impacts

  • Coroners and courts relying on flawed science
  • Industrial Injuries Advisory Council dependent on COT assessments
  • Aircrew face systemic barriers in occupational disease claims

 

5. What Parliament Should Do

A. Commission an independent statutory inquiry

To investigate:

  • authorship and drafting
  • omission of key toxicology
  • the role of DfT, CAA, UKHSA
  • transparency failures
  • potential conflicts of interest
  • adequacy of current monitoring and regulation

B. Require a new, fully independent scientific review

Led by:

  • independent toxicologists
  • neurologists
  • occupational physicians
  • environmental health scientists

With

  • full authorship disclosure
  • correct exposure modelling
  • proper evaluation of OP, VOC, UFP & CO toxicology
  • transparent, reproducible methodology

C. Mandate cabin-air sensors on all UK-registered aircraft

Including:

  • organophosphate detection
  • carbon monoxide detection
  • ultrafine particle monitoring
  • pyrolysis-related markers

D. Establish an occupational disease pathway for aircrew

Including:

  • ICD-10 coding and diagnostic criteria
  • toxicology testing (including VOC fat-biopsy analysis)
  • biomarker access (protein adducts, mitochondrial and endocrine markers)
  • clinical guidance and specialist referral routes
  • The medical protocol created by the Global Cabin Air Quality Executive (GCAQE) in the link below provides a vast amount of information:
    https://www.gcaqe.org/health

E. Create a centralised, publicly accessible registry of fume events

Reported in real time, consistent with other safety-critical industries.

F. Review historical incapacitation and mortality cases

Where toxic exposure may have been a factor.

 

6. What MPs Can Ask Immediately

Written Parliamentary Questions

  • “Who authored the drafts of the COT aircraft cabin air statements?”
  • “Why does UKHSA refuse to release the names?”
  • “What instructions were given to IEH Consulting Ltd by the Department for Transport?”
  • “Why was fume-event toxicology excluded?”
  • “Why were DEFRA organophosphate studies and protein adduct biomarkers not considered?”
  • “Why were endocrine and mitochondrial effects from repeated low-level exposures omitted?”
  • “What are the Government’s plans to mandate sensors and monitoring equipment onboard aircraft?”
  • “How many fume events have been reported to the CAA in the last 10 years?”

Select Committee routes

  • Transport Committee
  • Health and Social Care Committee
  • Public Administration and Constitutional Affairs Committee (PACAC)


Direct Ministerial engagement

  • Ministers at DfT, DHSC, UKHSA
  • The Aviation Minister

 

7. Conclusion

The COT cabin air review cannot be considered independent or scientifically valid.
Its conclusions are unreliable due to external authorship, withheld transparency, DfT constraints, exclusion of mechanistic toxicology, omission of critical evidence, and regulatory influence.

While contaminated air in aircraft and aircrew illness are recognised concerns internationally, the UK Government’s position - shaped by the COT, CAA and DfT - directly determines domestic aviation policy, clinical guidance, and regulatory action.

Aviation safety, public health, and the rights of injured crew now depend on an immediate independent re-evaluation.
Parliament is uniquely positioned to demand accountability and initiate the reforms needed to protect pilots, cabin crew, and passengers.

 

Final Appeal

A polite request to all UK citizens:
Please send this petition update to your local MP (as a PDF or copy–paste, along with the petition link) and ask them to take action by calling for an independent review of aircraft cabin air quality.

 

Further Information

For more on Aerotoxic Syndrome, scientific updates and articles and testimonies, visit Unfiltered VIP, run by Bearnairdine (Bee) Beaumont:
https://www.unfiltered.vip/

Bee’s personal story:
https://bee572.substack.com/about

 

Thank you for reading.

Wishing everyone a Merry and Joyful Christmas, and a Happy and Peaceful New Year.

 

 

Primary Sources -

  1. Early scientific and regulatory foundations (1920s–1950s)
    IG Farben/early OP chemistry

Gerhard Schrader, “Insektizide aus der Gruppe der organischen Phosphorverbindungen (OPVs),” I.G. Farbenindustrie AG research reports, 1930s–1940s.

(Original technical reports; many reproduced in post-war intelligence documents.)

U.S. War Department, Technical Manual: German Chemical Warfare (TM-E 30-451), 1945.

(Contains declassified summaries of IG Farben organophosphate research.)

Zuckerman Report (UK) – the first major recognition of chronic OP harm

Zuckerman, S., Review of the Evidence Relating to Organophosphorus Poisoning, Home Office / HSE predecessor, 1951.

(Foundational statement acknowledging cumulative toxicity, delayed neurotoxicity, and need for medical surveillance.)

2. Western and Eastern occupational studies (1960s–1980s)
These are the studies that David Ray (1998 review) and the COT cited in their tables:

Durham et al., “Cholinesterase Inhibition in Workers Using Organophosphate Pesticides,” Archives of Environmental Health, 1965.

Metcalf & Holmes, “EEG changes in workers exposed to organophosphates,” British Journal of Industrial Medicine, 1969.

Jager et al., “Neuromuscular effects of organophosphate exposure,” International Archives of Occupational Health, 1970.

Rayner et al., “Peripheral nerve conduction after organophosphate exposure,” British Journal of Industrial Medicine, 1972.

Korsak & Sato, “EEG and neuropsychological effects of pesticides,” Polish Journal of Occupational Medicine, 1977.

Stålberg et al., “Neuromuscular studies in asymptomatic pesticide sprayers,” Scandinavian Journal of Work, Environment & Health, 1978.

Duffy et al., “EEG β-activity in pesticide workers,” Electroencephalography and Clinical Neurophysiology, 1979.

These are the key primary-source studies that documented early EEG, autonomic, peripheral nerve, and neuropsychological effects long before regulators acknowledged them. Yet, the warnings contained in those studies were not heeded.

3. HSE - 1980’s
HSE translated document 1981 - immune effects 

http://www.oprus2001.co.uk/hseimmune.htm

U.K. HSE  MS17 -1980

http://www.oprus2001.co.uk/ms171980.pdf

U.K. HSE  MS17 -1987

http://www.oprus2001.co.uk/ms171987.pdf

4. MRC / IEH and COT (1990s)
David Ray’s 1998 review

Ray, D.E., Organophosphorus Esters: A Review of Putative Neurotoxic Effects in Humans, MRC Institute for Environment & Health (IEH), Leicester, 1998.

(The definitive pre-COT review; foundational to COT’s later interpretation.)

COT Annual Report 1998

Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment, Annual Report 1998, pp. 16–17.

(Notes receipt of Ray’s review and decision to form OP Working Group.)

COT 1999 OP Conclusions

COT, Organophosphates – Conclusions (often referred to as “1999 OP chapter” or “COT OP statement”).

(Official position: chronic low-dose effects ‘not convincing’, peripheral neuropathy ‘unlikely’, psychiatric effects ‘insufficient evidence’.)

The Guardian 2015 -

https://www.theguardian.com/environment/2015/apr/20/revealed-government-knew-of-farm-poisoning-risk-but-failed-to-act

5. Early aviation-specific medical evidence
Dr Peter Julu (autonomic neurophysiology) – 2007 Parliamentary Evidence

Julu, P., “Early Evidence of Specific Autonomic Neuropathy in Aircrews,” Written evidence to the UK House of Lords Science & Technology Committee, 17 June 2007.

(Primary clinical evidence that aircrew autonomic dysfunction matches OP-exposed farmers.)

BAe 146/Fume event reports

CAA (UK Civil Aviation Authority), Paper 985: Cabin Air Quality, 2004.

Australian Senate Inquiry, Air Safety & Cabin Air Quality in the BAe 146 Aircraft, 2000.

These are early governmental sources acknowledging cabin air contamination and organophosphate inhalation risks.

6. Mechanistic studies (2000s–2010s)
These dismantle the “only cholinesterase matters” dogma:

Li, Chen, & Casida, “Organophosphates bind directly to mouse brain proteins,” Proceedings of the National Academy of Sciences, 2007.

(Landmark proteomics study: non-AChE targets, adduct formation.)

Schopfer, Lockridge et al., “Human albumin adducts as biomarkers of organophosphate exposure,” Chemical Research in Toxicology, 2010–2013 series.

(Adduct biomarker evidence showing exposures missed by traditional tests.)

Abou-Donia et al., “Neurotoxicity of jet engine oil additives,” Journal of Toxicology and Environmental Health, 2013.

(Direct relevance to aviation; toxic effects of TOCP/TCP mixtures.)

7. COT position papers 
COT 2013 – Organophosphates: Updated Position Paper

COT, Organophosphates (OPs) – Update on Toxicology and Risk Assessment, 2013.

(Reasserts earlier stance; downplays chronic low-dose effects despite mechanistic advances.)

COT 2014 – Aircraft Cabin Air

COT, Statement on the Cabin Air Environment, Ill-health in Aircraft Crews and the Possible Relationship to Smoke/Fume Events, 2014.

(The definitive era, dismissal of a causal link and one of the most important policy-blocking documents in the field.)

8.  Modern REACH / ECHA evidence

Tricresyl Phosphate (TCP) Dossier

ECHA Registered Dossier for Tricresyl Phosphate (EC 247-759-6), Toxicokinetics section, 2014.

(Primary source showing industry claims: ‘low ortho isomer’, ‘low bioaccumulation’, ‘rapid excretion’, ‘not neurotoxic’.)

This document is a cornerstone example of the REACH “completeness, not correctness” problem.

9. Parliamentary and regulatory records (1980s–present)
House of Lords Science & Technology Committee, Air Travel and Health, 2000.

House of Commons Transport Committee, Aircraft Cabin Air Safety, 2007–2009.

Australian Senate, Inquiry into Air Safety and Cabin Air Quality, 2000.

EU Parliament, Cabin Air Quality – Resolution, 2013.

These sources demonstrate that the health effects of chronic low-level exposure to organophosphates — as part of complex chemical mixtures including aircraft oils, hydraulic fluids, and pesticides — have been repeatedly identified across decades, disciplines, and exposure contexts, yet have not been reflected in UK regulatory conclusions.

 

‘WE ARE SLOWLY BEING POISONED’

HOW TOXIC FUMES SEEP INTO THE AIR YOU BREATHE ON PLANES 

By Kiera Feldman - December 17, 2020 - Los Angeles Times

https://www.latimes.com/projects/toxic-chemicals-planes-covid-19-travel-woes/#nt=1colnt=0000017f-e095-d2a1-a57f-edfd2f910014-showMedia-title-promoSmall-enhancement

Jetzt unterstützen
Petition unterschreiben
Link kopieren
WhatsApp
Facebook
Nextdoor
E-Mail
X